The 16th IDSI ASM will be held on the
in the Royal Marine Hotel, Dun Laoghaire.
Advances and Innovations in Infectious Diseases
The IDSI will host their 16th Annual Scientific Meeting (ASM) in the Royal Marine Hotel, Dun Laoghaire, Co. Dublin on the 15th and 16th of May 2025. This year the focus will be on what is new in ID, we will be exploring how new developments are changing the clinical practice of Infectious Diseases professionals. It promises to be an inspiring and exciting meeting and we hope you can be part of it.
The conference dinner will be taking place in Hartleys Restaurant again this year and the cost for the dinner is €65 and can be added at registration
Key Dates for 2025
14/01: Abstract Submission Opens
18/03: Submission Closes
17/04: Notification of acceptances
x
x
I am a consultant in paediatric infectious diseases at Imperial College Healthcare NHS Trust and Professor of Practice at Imperial College. I lead the congenital infection clinics at St Mary’s Hospital in London. In 2020, with colleagues from around Europe, we set up CCMVNET ccmvnet@gmail.com an international network built around a prospective registry for children with congenital CMV (CCMV), I was the inaugural chair of the network (2020-2023). Our aim is to learn as much as possible about CCMV, and promote collaboration for research into prevention and treatment.
I am a member of the PENTA Network, and have participated in many HIV treatment and prevention trials for children. I have been actively involved in education for Paediatric Infections for many years, working with PENTA and ESPID supporting learning for clinicians, worldwide, particularly on congenital infections.
Fundamentally, I am a front line clinician and I love to bring people together – children, families and peer supporters ,clinicians, laboratory scientists, epidemiologists, virologists, pharmacologists, and trialists,– all the team that we need to change the future for children with congenital infections.
Panelist (2001-2022) and Coordinator (2020-2022), Spanish HIV Guidelines. Panelist (2007-2021) and Co-coordinator (2022-2024), Co-morbidities section, EACS Guidelines.
External consultant on HIV prevention and care for the Departament de Salut, Generalitat de Catalunya, the National AIDS Plan, Ministerio de Sanidad, España, and the European Medicines Agency (EMA). Member of the Hospital Medicine Advisory Board, Catalan Institute of Health, Generalitat de Catalunya.
External scientific advisor and reviewer of academic positions, grants, or doctoral theses to Dirección General de Investigación Científica y Técnica (Government of Spain), Agence Nationale de Recherche sur le Sida (France), UK Medical Research Council, Bundesministerium für Bildung und Forschung (Germany), HaDEA (European Commission), AIDS Clinical Trials Group (ACTG), South African Medical Research Council, Conselho Nacional de Desenvolvimento Científico e Tecnológico (Brazil), University of New South Wales, University of Dublin, University of Brighton, University College of London, and European AIDS Treatment Group (EATG).
Associate Editor of HIV Medicine and Journal of Antimicrobial Chemotherapy. Member of the Editorial Board of AIDS, AIDS Research and Therapy, Clinical Infectious Diseases, HIV Medicine, Journal of Acquired Immunodeficiency Syndromes, Journal of Antimicrobial Chemotherapy, and Journal of Infectious Diseases.
Martin McNally is Honorary Consultant in Limb Reconstruction at the Oxford Bone Infection Unit in the Nuffield Orthopaedic Centre, Oxford University Hospitals and King James IV Professor at the Royal College of Surgeons of Edinburgh.
He has a particular interest in fracture-related infection but is fascinated by all aspects of bone and joint infection, from pathogenesis to diagnosis in prosthetic joint infection to osteomyelitis. He has published over 250 peer-reviewed papers, reviews and book chapters. His current research and clinical studies focus on diagnosis and treatment options together with assessment of outcomes and quality of life for infection patients. He has been a champion of multi-disciplinary working in bone infection. He is Past-President of the European Bone and Joint Infection Society (EBJIS) and the Girdlestone Orthopaedic Society. He is a member of the EFORT Scientific Committee and Co-chair of the International Fracture-related Infection (FRI) Group.
Dr. José M. Miró has been Senior Consultant of Infectious Diseases at the Hospital Clinic – IDIBAPS of Barcelona since 2001. He is Professor of Medicine at the University of Barcelona, IDIBAPS and CIBERINFEC investigator and Director of the Master of HIV/AIDS of the University of Barcelona. His research fields are focused on infective endocarditis (including the experimental model) and HIV/AIDS (Cohort studies, primary HIV-1 infection, opportunistic Infections, late presenters, solid organ transplantation in HIV-1 infection, COVID-19). He has published almost 1,000 articles in peer-review journals (h-index 94).
Dr. Miro was President of GESIDA (1998-99), the Catalan Society of Infectious Diseases and Clinical Microbiology (SCMIMC, 2005-07), the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC, 2013-15) and currently is President of the International Society of Cardiovascular Infectious Diseases (ISCVID, 2019-27). In 2023 and 2024 he was nominated ESCMID and IDSA Fellow, respectively. In 2024 Dr. Miro was elected Academician of the Catalonian Academy of Medical Sciences (RAMC).
Yashna Singh is a medical doctor at the Desmond Tutu Health Foundation Clinical Trials Unit in Cape Town, South Africa. She is the site lead on HIV prevention and treatment trials, including novel injectable HIV treatment and PrEP trials and phase 1 analytical treatment interruption studies with broadly neutralizing antibodies.
Yashna has a passion for HIV and sexual health research in young women and gender-diverse people. She has an active role in community and stakeholder engagement and is committed to capacity building to ensure equitable access to novel HIV PrEP products.
Andrej Spec earned his MD at the University of Illinois in Chicago and did his internal medicine training at Rush University Medical Center. He came to Washington University in St Louis for his fellowship, and concomitantly earned his Masters of Science in Clinical Investigation. He stayed on as faculty, where he focused his research and clinical work on invasive fungal infections. He is currently an Associate Professor at Washington University in St Louis, where he also serves as the Associate Director of the Infectious Disease Clinical Research Unit, the Medical Co-Director of the Invasive Mycoses Clinic and the Section Director of Transplant Infectious Disease. He has authored over 80 scientific papers and several book chapters on invasive fungal infections. He has also served as the Interim Co-Editor-in-Chief for Open Forum Infectious Disease and is currently the Deputy Editor. Dr. Spec was elected as a Fellow by the European Confederation of Medical Mycologists and Infectious Disease Society of America in 2019, and 2021, respectively. Finally, he is the developer and lead editor of the Comprehensive Review of Infectious Disease, a bestselling Infectious Disease textbook with a focus on teaching ID and preparing readers for ID boards.
Dr. Aoife Cotter is an Infectious Diseases Consultant and has been looking after patients with HIV, viral hepatitis, TB and other infectious diseases at the Mater Misericordiae University Hospital (MMUH) since. She is the CEPHR (Centre for Experimental Pathogen Host Clinical (MMUH) and Data Programme Lead. Since completing a PhD in 2014 (co-supervisors at CEPHR, UCD & Institute for Global Health, University College Dublin), she has developed her interest in cohort methodology as an investigator for the HIV UPBEAT Cohort, the All Ireland Infectious Diseases Cohort, TRACER (hepatitis C treatment cohort study), SORTED (SARS-CoV-2 in healthcare workers), the UK- Ireland POPPY Trial (frailty and ageing in people with HIV) and the National Irish COVID Biobank. As site lead for the ID Clinical Trial Network, she is a PI for trials at MMUH including the SWIFT and LAPTOP Studies. She is a full member of the European AIDS Clinical Society Guidelines for the management of HIV.
Dr Eavan Muldoon is a consultant in Infectious Diseases in the Mater Misericordiae University Hospital and the National Clinical Lead for the Clinical Programme in Infectious Diseases and OPAT in the HSE.
Dr Muldoon graduated from University College Dublin with honours and completed Infectious Diseases Specialist registrar training in Ireland, completing a Doctor of Medicine (Trinity College Dublin) during that time . Following her training in Ireland, she completed a fellowship in Infectious Diseases and Transplant Infectious Diseases, in Tufts Medical Center Boston. She was the inaugural recipient of the Frank P. Tally Fellowship in Infectious Diseases in Tufts Medical Center, and was awarded the Kass award for clinical excellence from the Massachusetts Infectious Diseases Society. She also completed a Masters of Public Health in Tufts University Boston.
On completion of fellowship, Dr Muldoon joined the team in the National Aspergillosis Centre in Manchester, where she worked as a Consultant in Infectious Diseases, and Honorary Senior Clinical Lecturer with the University of Manchester for four years. In April 2017 she returned to Dublin to take up a post as Consultant in Infectious Diseases in the Mater Misericordiae University Hospital.
She has a keen interest in clinical mycology, antimicrobial stewardship and outpatient parenteral antimicrobial therapy (OPAT).